Opko Health(IL:OPK)
ILA 541.60-6.40 (-1.17%)
IL:OPK
Opko Health stock drug pipeline
ILA 541.60
At close:-6.40 (-1.17%)
Opko Health (OPK) Drug Pipeline
4 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Opko Health (IL:OPK) have in its pipeline
Opko Health IL:OPK is currently developing the following drugs: Ctap101, Opk-88006, Calcifediol Oral Capsule, Mod-4023, Somatropin, Mod-4023. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

